Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 2
1969 3
1970 3
1971 2
1972 3
1973 3
1974 1
1975 6
1976 4
1977 3
1978 2
1979 6
1980 2
1981 6
1982 3
1983 4
1984 2
1985 3
1986 5
1987 4
1988 4
1989 6
1990 8
1991 4
1992 11
1993 8
1994 8
1995 8
1996 11
1997 7
1998 7
1999 12
2000 13
2001 11
2002 18
2003 17
2004 13
2005 15
2006 24
2007 24
2008 22
2009 17
2010 36
2011 44
2012 41
2013 45
2014 31
2015 35
2016 41
2017 50
2018 39
2019 36
2020 46
2021 44
2022 36
2023 24
2024 36
2025 39
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

864 results

Results by year

Filters applied: . Clear all
The following terms were ignored: AND, (
Page 1
Lectin pathway of complement in SLE: MAP-1 as a marker of haematological manifestations and elevated type I interferon activity.
Lindelöf L, Garred P, Hong MG, Wahl Vælum S, Holten Petersen L, Leonard D, Sayadi A, Oke V, Niewold TB, Diaz-Gallo LM, Saevarsdottir S, Gunnarsson I, Svenungsson E, Eriksson O. Lindelöf L, et al. Among authors: niewold tb. Lupus Sci Med. 2026 Apr 9;13(1):e001890. doi: 10.1136/lupus-2025-001890. Lupus Sci Med. 2026. PMID: 41956715 Free article.
Comparative effects of caffeine and paraxanthine on rowing performance and sleep quality: a randomized crossover study.
Bingol Diedhiou A, Yildirim UC, Ozdenk S, Erkan D, Karakulak I, Yildirim Tuncer S, Turğut M, Gundem MC, Bora MV, Akca F. Bingol Diedhiou A, et al. Among authors: erkan d. J Int Soc Sports Nutr. 2026 Dec 31;23(1):2650339. doi: 10.1080/15502783.2026.2650339. Epub 2026 Mar 31. J Int Soc Sports Nutr. 2026. PMID: 41918248 Free PMC article. Clinical Trial.
Acute effects of combined and isolated caffeine and theanine supplementation on physical and cognitive performance in competitive athletes: a randomized, double-blind, placebo-controlled crossover study.
Tuncer SY, Ozdenk S, Yildirim UC, Erkan D, Sari C, Gundem MC, Sar H, Yilmaz B, Karakulak I, Akca F. Tuncer SY, et al. Among authors: erkan d. Front Nutr. 2026 Jan 26;12:1751673. doi: 10.3389/fnut.2025.1751673. eCollection 2025. Front Nutr. 2026. PMID: 41668720 Free PMC article.
Erratum to '2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria solid phase-based antiphospholipid antibody domain-collaborative efforts of Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking and ISTH SSC to harmonize enzyme-linked immunosorbent assay and non-enzyme-linked immunosorbent assay antiphospholipid antibody tests: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies': [Journal of Thrombosis and Haemostasis. Volume 23, Issue 1, January 2025, Pages 341-344].
Meroni PL, Borghi MO, Amengual O, Atsumi T, Bertolaccini ML, Cohen H, Grossi C, Roubey R, Sciascia S, Tebo A, Willis R, Erkan D, Devreese KMJ. Meroni PL, et al. Among authors: erkan d. J Thromb Haemost. 2026 Mar;24(3):1209-1210. doi: 10.1016/j.jtha.2026.01.001. Epub 2026 Jan 13. J Thromb Haemost. 2026. PMID: 41535144 No abstract available.
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains.
Barbhaiya M, Zuily S, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus GR, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou MG, Wahl D, Willis R, Hendry A, Naden R, Costenbader KH, Erkan D; New APS Classification Criteria Collaborators. Barbhaiya M, et al. Among authors: erkan d, lockshin md. Curr Rheumatol Rep. 2025 Nov 26;27(1):41. doi: 10.1007/s11926-025-01202-y. Curr Rheumatol Rep. 2025. PMID: 41296194 Review.
Renal Replacement Therapy in Lupus Nephritis-Related End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.
Kawtharany H, Jorge A, Azzam M, Bartels CM, Cunha JS, DeQuattro K, Fava A, Figueroa-Parra G, Garg S, Greco J, Cuéllar-Gutiérrez MC, Iyer P, Johannemann AS, Kasturi S, Khawandi J, Kirou KA, Legge A, Liang KV, Lockwood MM, Sanchez-Rodriguez A, Turgunbaev M, Williams JN, Sammaritano LR, Askanase A, Bermas BL, Dall'Era M, Duarte-García A, Hiraki LT, Rovin B, Son MBF, Turner AS, Mustafa RA. Kawtharany H, et al. Among authors: sammaritano lr, kirou ka. ACR Open Rheumatol. 2025 Dec;7(12):e70121. doi: 10.1002/acr2.70121. ACR Open Rheumatol. 2025. PMID: 41294263 Free PMC article. Review.
864 results